Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Feb 15;99(4):725–731. doi: 10.1172/JCI119217

Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus.

B P Tsao 1, R M Cantor 1, K C Kalunian 1, C J Chen 1, H Badsha 1, R Singh 1, D J Wallace 1, R C Kitridou 1, S L Chen 1, N Shen 1, Y W Song 1, D A Isenberg 1, C L Yu 1, B H Hahn 1, J I Rotter 1
PMCID: PMC507856  PMID: 9045876

Abstract

Genetic susceptibility confers significant risk for systemic lupus erythematosus (SLE). The MHC region and other polymorphic loci have been associated with SLE. Because more compelling evidence for an involvement of a genetic locus includes linkage, we tested a candidate region homologous to a murine SLE susceptibility region in 52 SLE-affected sibpairs from three ethnic groups. We analyzed seven microsatellite markers from the human chromosome 1q31-q42 region corresponding to the telomeric end of mouse chromosome 1, the region where specific manifestations of murine lupus, including glomerulonephritis and IgG antichromatin, have been mapped. Comparing the mean allele sharing in affected sibpairs of each of these seven markers to their expected values of 0.50, only the five markers located at 1q41-q42 showed evidence for linkage (P = 0.0005-0.08). Serum levels of IgG antichromatin also showed evidence for linkage to two of these five markers (P = 0.04), suggesting that this phenotype is conserved between mice and humans. Compared to the expected random distribution, the trend of increased sharing of haplotypes was observed in affected sibpairs from three ethnic groups (P < 0.01). We concluded that this candidate 1q41-q42 region probably contains a susceptibility gene(s) that confers risk for SLE in multiple ethnic groups.

Full Text

The Full Text of this article is available as a PDF (180.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barton D. E., Foellmer B. E., Du J., Tamm J., Derynck R., Francke U. Chromosomal mapping of genes for transforming growth factors beta 2 and beta 3 in man and mouse: dispersion of TGF-beta gene family. Oncogene Res. 1988;3(4):323–331. [PubMed] [Google Scholar]
  2. Bell D. A., Morrison B., VandenBygaart P. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest. 1990 May;85(5):1487–1496. doi: 10.1172/JCI114595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bettinotti M. P., Hartung K., Deicher H., Messer G., Keller E., Weiss E. H., Albert E. D. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics. 1993;37(6):449–454. doi: 10.1007/BF00222469. [DOI] [PubMed] [Google Scholar]
  4. Blackwelder W. C., Elston R. C. A comparison of sib-pair linkage tests for disease susceptibility loci. Genet Epidemiol. 1985;2(1):85–97. doi: 10.1002/gepi.1370020109. [DOI] [PubMed] [Google Scholar]
  5. Botto M., Theodoridis E., Thompson E. M., Beynon H. L., Briggs D., Isenberg D. A., Walport M. J., Davies K. A. Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol. 1996 May;104(2):264–268. doi: 10.1046/j.1365-2249.1996.33740.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bowness P., Davies K. A., Norsworthy P. J., Athanassiou P., Taylor-Wiedeman J., Borysiewicz L. K., Meyer P. A., Walport M. J. Hereditary C1q deficiency and systemic lupus erythematosus. QJM. 1994 Aug;87(8):455–464. [PubMed] [Google Scholar]
  7. Burlingame R. W., Boey M. L., Starkebaum G., Rubin R. L. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest. 1994 Jul;94(1):184–192. doi: 10.1172/JCI117305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burlingame R. W., Rubin R. L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods. 1990 Dec 5;134(2):187–199. doi: 10.1016/0022-1759(90)90380-e. [DOI] [PubMed] [Google Scholar]
  9. Copeman J. B., Cucca F., Hearne C. M., Cornall R. J., Reed P. W., Rønningen K. S., Undlien D. E., Nisticò L., Buzzetti R., Tosi R. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet. 1995 Jan;9(1):80–85. doi: 10.1038/ng0195-80. [DOI] [PubMed] [Google Scholar]
  10. Cordell H. J., Todd J. A. Multifactorial inheritance in type 1 diabetes. Trends Genet. 1995 Dec;11(12):499–504. doi: 10.1016/s0168-9525(00)89160-x. [DOI] [PubMed] [Google Scholar]
  11. Cornillet P., Gredy P., Pennaforte J. L., Meyer O., Kazatchkine M. D., Cohen J. H. Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus. Clin Exp Immunol. 1992 Jul;89(1):22–25. doi: 10.1111/j.1365-2249.1992.tb06871.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Davies E. J., Snowden N., Hillarby M. C., Carthy D., Grennan D. M., Thomson W., Ollier W. E. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum. 1995 Jan;38(1):110–114. doi: 10.1002/art.1780380117. [DOI] [PubMed] [Google Scholar]
  13. Deguchi Y., Agus D., Kehrl J. H. A human homeobox gene, HB24, inhibits development of CD4+ T cells and impairs thymic involution in transgenic mice. J Biol Chem. 1993 Feb 15;268(5):3646–3653. [PubMed] [Google Scholar]
  14. Drake C. G., Babcock S. K., Palmer E., Kotzin B. L. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4062–4066. doi: 10.1073/pnas.91.9.4062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Drake C. G., Rozzo S. J., Hirschfeld H. F., Smarnworawong N. P., Palmer E., Kotzin B. L. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J Immunol. 1995 Mar 1;154(5):2441–2447. [PubMed] [Google Scholar]
  16. Duits A. J., Bootsma H., Derksen R. H., Spronk P. E., Kater L., Kallenberg C. G., Capel P. J., Westerdaal N. A., Spierenburg G. T., Gmelig-Meyling F. H. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 1995 Dec;38(12):1832–1836. doi: 10.1002/art.1780381217. [DOI] [PubMed] [Google Scholar]
  17. Green J. R., Woodrow J. C. Sibling Method for Detecting HLA-linked genes in disease. Tissue Antigens. 1977 Jan;9(1):31–35. doi: 10.1111/j.1399-0039.1977.tb01076.x. [DOI] [PubMed] [Google Scholar]
  18. Harley J. B., Sheldon P., Neas B., Murphy S., Wallace D. J., Scofield R. H., Shaver T. S., Moser K. L. Systemic lupus erythematosus: considerations for a genetic approach. J Invest Dermatol. 1994 Nov;103(5 Suppl):144S–149S. doi: 10.1111/1523-1747.ep12399472. [DOI] [PubMed] [Google Scholar]
  19. Haseman J. K., Elston R. C. The investigation of linkage between a quantitative trait and a marker locus. Behav Genet. 1972 Mar;2(1):3–19. doi: 10.1007/BF01066731. [DOI] [PubMed] [Google Scholar]
  20. Haug B. L., Lee J. S., Sibley J. T. Altered poly(ADP-ribose) metabolism in family members of patients with systemic lupus erythematosus. J Rheumatol. 1994 May;21(5):851–856. [PubMed] [Google Scholar]
  21. Herzog H., Zabel B. U., Schneider R., Auer B., Hirsch-Kauffmann M., Schweiger M. Human nuclear NAD+ ADP-ribosyltransferase: localization of the gene on chromosome 1q41-q42 and expression of an active human enzyme in Escherichia coli. Proc Natl Acad Sci U S A. 1989 May;86(10):3514–3518. doi: 10.1073/pnas.86.10.3514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hoffman R. W., Sharp G. C., Irvin W. S., Anderson S. K., Hewett J. E., Pandey J. P. Association of immunoglobulin Km and Gm allotypes with specific antinuclear antibodies and disease susceptibility among connective tissue disease patients. Arthritis Rheum. 1991 Apr;34(4):453–458. doi: 10.1002/art.1780340410. [DOI] [PubMed] [Google Scholar]
  23. Jacob C. O., Fronek Z., Lewis G. D., Koo M., Hansen J. A., McDevitt H. O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1233–1237. doi: 10.1073/pnas.87.3.1233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jarjour W., Reed A. M., Gauthier J., Hunt S., 3rd, Winfield J. B. The 8.5-kb PstI allele of the stress protein gene, Hsp70-2: an independent risk factor for systemic lupus erythematosus in African Americans? Hum Immunol. 1996 Jan;45(1):59–63. doi: 10.1016/0198-8859(95)00153-0. [DOI] [PubMed] [Google Scholar]
  25. Kono D. H., Burlingame R. W., Owens D. G., Kuramochi A., Balderas R. S., Balomenos D., Theofilopoulos A. N. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10168–10172. doi: 10.1073/pnas.91.21.10168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kotzin B. L. Systemic lupus erythematosus. Cell. 1996 May 3;85(3):303–306. doi: 10.1016/s0092-8674(00)81108-3. [DOI] [PubMed] [Google Scholar]
  27. Kumar A., Kumar A., Sinha S., Khandekar P. S., Banerjee K., Srivastava L. M. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon. Immunol Cell Biol. 1995 Oct;73(5):457–462. doi: 10.1038/icb.1995.71. [DOI] [PubMed] [Google Scholar]
  28. Kuokkanen S., Sundvall M., Terwilliger J. D., Tienari P. J., Wikström J., Holmdahl R., Pettersson U., Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat Genet. 1996 Aug;13(4):477–480. doi: 10.1038/ng0896-477. [DOI] [PubMed] [Google Scholar]
  29. Lander E. S., Schork N. J. Genetic dissection of complex traits. Science. 1994 Sep 30;265(5181):2037–2048. doi: 10.1126/science.8091226. [DOI] [PubMed] [Google Scholar]
  30. Loetscher P., Alvarez-Gonzalez R., Althaus F. R. Poly(ADP-ribose) may signal changing metabolic conditions to the chromatin of mammalian cells. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1286–1289. doi: 10.1073/pnas.84.5.1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mohan C., Adams S., Stanik V., Datta S. K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993 May 1;177(5):1367–1381. doi: 10.1084/jem.177.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Morel L., Rudofsky U. H., Longmate J. A., Schiffenbauer J., Wakeland E. K. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity. 1994 Jun;1(3):219–229. doi: 10.1016/1074-7613(94)90100-7. [DOI] [PubMed] [Google Scholar]
  33. Morel L., Yu Y., Blenman K. R., Caldwell R. A., Wakeland E. K. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome. 1996 May;7(5):335–339. doi: 10.1007/s003359900098. [DOI] [PubMed] [Google Scholar]
  34. Morton N. E., Collins A., Lawrence S., Shields D. C. Algorithms for a location database. Ann Hum Genet. 1992 Jul;56(Pt 3):223–232. doi: 10.1111/j.1469-1809.1992.tb01147.x. [DOI] [PubMed] [Google Scholar]
  35. Nishimura D. Y., Purchio A. F., Murray J. C. Linkage localization of TGFB2 and the human homeobox gene HLX1 to chromosome 1q. Genomics. 1993 Feb;15(2):357–364. doi: 10.1006/geno.1993.1068. [DOI] [PubMed] [Google Scholar]
  36. Ohnishi K., Ebling F. M., Mitchell B., Singh R. R., Hahn B. H., Tsao B. P. Comparison of pathogenic and non-pathogenic murine antibodies to DNA: antigen binding and structural characteristics. Int Immunol. 1994 Jun;6(6):817–830. doi: 10.1093/intimm/6.6.817. [DOI] [PubMed] [Google Scholar]
  37. Raz E., Dudler J., Lotz M., Baird S. M., Berry C. C., Eisenberg R. A., Carson D. A. Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus. 1995 Aug;4(4):286–292. doi: 10.1177/096120339500400409. [DOI] [PubMed] [Google Scholar]
  38. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet. 1987 Jan;40(1):1–14. [PMC free article] [PubMed] [Google Scholar]
  39. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet. 1990 Feb;46(2):229–241. [PMC free article] [PubMed] [Google Scholar]
  40. Salmon J. E., Millard S., Schachter L. A., Arnett F. C., Ginzler E. M., Gourley M. F., Ramsey-Goldman R., Peterson M. G., Kimberly R. P. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest. 1996 Mar 1;97(5):1348–1354. doi: 10.1172/JCI118552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Schur P. H., Pandey J. P., Fedrick J. A. Gm allotypes in white patients with systemic lupus erythematosus. Arthritis Rheum. 1985 Jul;28(7):828–830. doi: 10.1002/art.1780280716. [DOI] [PubMed] [Google Scholar]
  42. Schur P. H., Pandey J. P., Fedrick J. A. Gm allotypes in white patients with systemic lupus erythematosus. Arthritis Rheum. 1985 Jul;28(7):828–830. doi: 10.1002/art.1780280716. [DOI] [PubMed] [Google Scholar]
  43. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  44. Tebib J. G., Alcocer-Varela J., Alarcon-Segovia D., Schur P. H. Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus. J Clin Invest. 1990 Dec;86(6):1961–1967. doi: 10.1172/JCI114930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Theofilopoulos A. N. The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today. 1995 Mar;16(3):150–159. doi: 10.1016/0167-5699(95)80133-2. [DOI] [PubMed] [Google Scholar]
  46. Thomson G. Identifying complex disease genes: progress and paradigms. Nat Genet. 1994 Oct;8(2):108–110. doi: 10.1038/ng1094-108. [DOI] [PubMed] [Google Scholar]
  47. Tsao B. P., Ohnishi K., Cheroutre H., Mitchell B., Teitell M., Mixter P., Kronenberg M., Hahn B. H. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol. 1992 Jul 1;149(1):350–358. [PubMed] [Google Scholar]
  48. Tsugu H., Horowitz R., Gibson N., Frank M. B. The location of a disease-associated polymorphism and genomic structure of the human 52-kDa Ro/SSA locus (SSA1). Genomics. 1994 Dec;24(3):541–548. doi: 10.1006/geno.1994.1664. [DOI] [PubMed] [Google Scholar]
  49. Vyse T. J., Todd J. A. Genetic analysis of autoimmune disease. Cell. 1996 May 3;85(3):311–318. doi: 10.1016/s0092-8674(00)81110-1. [DOI] [PubMed] [Google Scholar]
  50. Watson M. L., Rao J. K., Gilkeson G. S., Ruiz P., Eicher E. M., Pisetsky D. S., Matsuzawa A., Rochelle J. M., Seldin M. F. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992 Dec 1;176(6):1645–1656. doi: 10.1084/jem.176.6.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Wu D. A., Bu X., Warden C. H., Shen D. D., Jeng C. Y., Sheu W. H., Fuh M. M., Katsuya T., Dzau V. J., Reaven G. M. Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. J Clin Invest. 1996 May 1;97(9):2111–2118. doi: 10.1172/JCI118648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. de Martin R., Haendler B., Hofer-Warbinek R., Gaugitsch H., Wrann M., Schlüsener H., Seifert J. M., Bodmer S., Fontana A., Hofer E. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J. 1987 Dec 1;6(12):3673–3677. doi: 10.1002/j.1460-2075.1987.tb02700.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES